Sunitinib malate is used for the treatment of patients with renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST)

Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications

Sunitinib malate suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Sunitinib malate brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Sunitinib malate medicine cost price in India.

The order for Sunitinib malate will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

SUTENT® (sunitinib malate) capsules, oral Initial U.S. Approval: 2006

Generic Name: sunitinib malate

Capsules: 12.5 mg, 25 mg, 50 mg.

Sunitinib

sunitinib malate Capsules is available.

Get In Touch

Sunitinib malate suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Sunitinib malate on prescription and Import License in Patient's Name only.

For overseas patients, Sunitinib malate can be made available in Send your enquiry to find Sunitinib malate in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for SUTENT (sunitinib malate).

For SUTENT (sunitinib malate) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA expands approval of Sutent to reduce the risk of kidney cancer returning For More Details

Immunotherapy Brings More Options for Frontline RCC Treatment For More Details

Channel Partner In India

NEW DELHI OFFICE

  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi

BANGALORE OFFICE

  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore

KOLKATA OFFICE

  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata

LUCKNOW OFFICE

  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow